Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.955 USD | -6.81% | -2.02% | -7.95% |
May. 20 | Top Premarket Decliners | MT |
Mar. 06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 387M 284M |
---|---|---|---|---|---|
Net income 2024 * | -46M -33.77M | Net income 2025 * | -72M -52.85M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.43
x | P/E ratio 2025 * |
-6.28
x | Employees | 50 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.73% |
Latest transcript on ESSA Pharma Inc.
1 day | +1.43% | ||
1 week | +2.40% | ||
Current month | -0.62% | ||
1 month | +5.10% | ||
3 months | -25.26% | ||
6 months | +8.31% | ||
Current year | -3.18% |
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 5.95 | -6.88% | 66 524 |
24-05-24 | 6.39 | +1.43% | 94,799 |
24-05-23 | 6.3 | +1.61% | 52,377 |
24-05-22 | 6.2 | 0.00% | 58,552 |
24-05-21 | 6.2 | -0.64% | 74,780 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.18% | 283M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+42.32% | 40.47B | |
-10.02% | 27.17B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- EPIX Stock